News
2h
Zacks Investment Research on MSNRegeneron (REGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
The market expects Regeneron (REGN) to deliver a year-over-year decline in earnings on lower revenues when it reports results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results